These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

345 related articles for article (PubMed ID: 6227511)

  • 1. Cyproterone acetate prevents translocation of the androgen receptor in the rat prostate.
    Brinkmann AO; Lindh LM; Breedveld DI; Mulder E; Van Der Molen HJ
    Mol Cell Endocrinol; 1983 Oct; 32(2-3):117-29. PubMed ID: 6227511
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interactions of an anti-androgen (cyproterone acetate) with the androgen receptor system and its biological action in the rat ventral prostate.
    Huang JK; Bartsch W; Voigt KD
    Acta Endocrinol (Copenh); 1985 Aug; 109(4):569-76. PubMed ID: 2930988
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interaction of cyproterone acetate with rat prostatic androgen receptors.
    Traish AM; Muller RE; Wotiz HH
    Steroids; 1985; 45(3-4):247-62. PubMed ID: 2939604
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Androgen receptor in rat skeletal muscle: characterization and physiological variations.
    Michel G; Baulieu EE
    Endocrinology; 1980 Dec; 107(6):2088-98. PubMed ID: 6968675
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of a [3H]methyltrienolone (R1881) binding protein in rat liver cytosol.
    Levinson DJ; Decker DE
    J Steroid Biochem; 1985 Feb; 22(2):211-9. PubMed ID: 3872380
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of androgen binding in human foreskin fibroblasts by antiandrogens.
    Brown TR; Rothwell SW; Sultan C; Migeon CJ
    Steroids; 1981 Jun; 37(6):635-48. PubMed ID: 6457421
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Androgen receptor binding characteristics in the cytosol of the rat dorsolateral prostate gland and the Dunning R-3327 prostatic adenocarcinoma.
    Rowley DR; Thompson SA; Lubaroff DM; Heidger PM
    Prostate; 1984; 5(1):101-11. PubMed ID: 6607463
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differences in the physicochemical characteristics of androgen-receptor complexes formed in vivo and in vitro.
    Traish AM; Müller RE; Wotiz HH
    Endocrinology; 1984 May; 114(5):1761-9. PubMed ID: 6609069
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Partial characterization of [3H]methyltrienolone binding in rat prostate cytosol.
    Pousette A; Snochowski M; Bression D; Högberg B; Gustafsson JA
    Biochim Biophys Acta; 1979 Jan; 582(2):358-67. PubMed ID: 760830
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Binding of glucocorticoid to the androgen receptor of mouse submandibular glands.
    Maruyama S; Sato S
    J Endocrinol; 1985 Sep; 106(3):329-35. PubMed ID: 2931495
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Changes in the cytoplasmic androgen receptor of rat ventral prostate after administration of androgens, antiandrogens and anabolic steroids.
    Ichii S
    Endocrinol Jpn; 1980 Aug; 27(4):483-93. PubMed ID: 7460859
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Control of androgen cytosol receptor concentrations in Sertoli cells: effect of androgens.
    Sanborn BM; Wagle JR; Steinberger A
    Endocrinology; 1984 Jun; 114(6):2388-93. PubMed ID: 6202501
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of 5 alpha-reductase, receptor binding, and nuclear uptake of androgens in the prostate by a 4-methyl-4-aza-steroid.
    Liang T; Heiss CE
    J Biol Chem; 1981 Aug; 256(15):7998-8005. PubMed ID: 7263637
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nuclear androgen receptors in prostates from diabetic rats.
    Tesone M; Oliveira-Filho RM; Valle LB; Barañao JL; Foglia VG; Charreau EH
    Horm Metab Res; 1982 May; 14(5):237-40. PubMed ID: 7047345
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Androgen interactions with intact nuclear envelopes from the rat ventral prostate.
    Lefebvre YA; Golsteyn EJ; Michiel TL
    J Steroid Biochem; 1985 Jul; 23(1):107-13. PubMed ID: 3160891
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A quantitative assay for the cytoplasmic androgen receptor using [3H]dihydrotestosterone in the presence of NAD+-nucleosidase.
    Moeller H; Oettling G; Fiederer B; Brügmann G
    Acta Endocrinol (Copenh); 1983 Jan; 102(1):153-60. PubMed ID: 6297214
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Binding of Permixon, a new treatment for prostatic benign hyperplasia, to the cytosolic androgen receptor in the rat prostate.
    Carilla E; Briley M; Fauran F; Sultan C; Duvilliers C
    J Steroid Biochem; 1984 Jan; 20(1):521-3. PubMed ID: 6200701
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Androgens and androgen-receptors in prostate tissue from patients with benign prostatic hyperplasia: effects of cyproterone acetate.
    de Jong FH; Reuvers PJ; Bolt-de Vries J; Mulder E; Blom JH; Schroeder FH
    J Steroid Biochem Mol Biol; 1992 Mar; 42(1):49-55. PubMed ID: 1373073
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Androgen receptors in experimentally induced colon carcinogenesis.
    Izbicki JR; Wambach G; Hamilton SR; Harnisch E; Hogenschurz R; Izbicki W; Kusche J
    J Cancer Res Clin Oncol; 1986; 112(1):39-46. PubMed ID: 2942549
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Androgen-dependent growth regulation of and release of specific protein(s) by the androgen receptor containing human prostate tumor cell line LNCaP.
    Berns EM; de Boer W; Mulder E
    Prostate; 1986; 9(3):247-59. PubMed ID: 2946029
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.